Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

In vivo immunisation and reaction against TNP-modified splenocytes

Abstract

CYTOTOXICITY tests in vitro detect some components of the graft rejection reaction. In one such test, antigenically modified (hapten trinitrophenyl TNP) mouse lymphocytes are detected by the action of cytolytic T lymphocytes (CTL) if the sensitisation of the effector cells is carried out in vitro1. In the CTL test there is evidence2 that the reaction is not against the hapten, but against antigenic membrane groups coded by H–2D and H–2K genes, a phenomenon termed ‘H–2 restriction’. In contrast, immunisation in vivo with TNP-modified lymphocytes results in a low production of CTL as detected in vitro, due probably to production of T suppressor cells3. The aim of the present work was to compare the in vivo efficacy of the response of the TNP splenocytes with that obtained in vitro, and to determine whether the H–2 restriction applies. Our results show that the immunogenetic implications differed according to whether the test was carried out in vivo or in vitro, and suggest that the effectors for target cell destruction are also different.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Shearer, G. M. Eur. J. Immun. 4, 527–533 (1974).

    Article  CAS  Google Scholar 

  2. Shearer, G. M. Transplant. Proc. 9, 853–857 (1977).

    CAS  PubMed  Google Scholar 

  3. Röllinghof, M., Starzinski-Powitz, I., Pfizenmayer, K. & Wagner, H. J. exp. Med. 145, 455–459 (1977).

    Article  Google Scholar 

  4. Bainbridge, D. R. & Gowland, G. Ann. N. Y. Acad. Sci. 129, 257–273 (1966).

    Article  ADS  Google Scholar 

  5. Burstein, N. A. Rev. Eur. Etudes clin. Bio. 15, 873–875 (1970).

    CAS  Google Scholar 

  6. Brand, K. G., Buoen, L. C. & Brand, I. J. natn. Cancer Inst. 49, 459–465 (1972).

    CAS  Google Scholar 

  7. Gordon, R. D., Simpson, E. & Samuelson, L. E. J. exp. Med. 142, 1108–1120 (1975).

    Article  CAS  Google Scholar 

  8. Bevan, M. J. Immunogenetics 3, 177–184 (1976).

    Article  Google Scholar 

  9. Wettstein, P. J., Haughton, G. & Frelinger, J. A. J. exp. Med. 146, 1346–1355 (1977).

    Article  CAS  Google Scholar 

  10. Matzinger, P. & Bevan, M. J. Cell. Immun. 33, 92–100 (1977).

    Article  CAS  Google Scholar 

  11. Wachtel, S. S., Gasser, D. L. & Silvers, W. K. Science 181, 862–863 (1973).

    Article  ADS  CAS  Google Scholar 

  12. Katz, D. H. Lymphocyte Differentiation, Recognition and Regulation (Academic, New York, 1970).

    Google Scholar 

  13. Burakoff, S. J., Germain, R. N. & Benacerraf, B. J. exp. Med. 144, 1609–1620 (1976).

    Article  CAS  Google Scholar 

  14. Dennert, G. & Hyman, R. Eur. J. Immun. 7, 251–257 (1977).

    Article  CAS  Google Scholar 

  15. Dennert, G. Nature 255, 712–713 (1975).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BISCHOFF, P., OTH, D. In vivo immunisation and reaction against TNP-modified splenocytes. Nature 274, 806–808 (1978). https://doi.org/10.1038/274806a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/274806a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing